ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,996.66
1.00%
Dow Jones
43,487.83
0.78%
US Dollar vs MXN
20.7918
0.00%
Brent Oil
80.005
0.00%
Bitcoin
103,639.85
-0.46%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Europa
  5. EU

  6. Arcure SA (ALCUR) Cotización

Arcure SA

Arcure SA (ALCUR)

EU
4.63
-0.04
(-0.86%)
Cerrado 17 Enero 10:30AM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
4.63
Postura de Compra
4.61
Postura de Venta
4.67
Volume Operado de la Acción
15,347
4.60 Rango del Día 4.67
3.15 Rango de 52 semanas 6.96
Capitalización de Mercado [m]
26.602M
Precio Anterior
4.67
Precio de Apertura
4.64
Hora
5
@
4.63
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
29,783
Acciones en circulación
5,745,489
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
14.77
Beneficio por acción (BPA)
0.31
turnover
19.17M
Beneficio neto
1.8M

Acerca de Arcure SA

Sector
Motor Vehicle Part,accessory
Industria
Motor Vehicle Part,accessory
Sitio web
www.arcure-bourse.com
Sede
Pantin, Seine-saint-denis, Fra
Fundado
-
Arcure SA is listed in the Motor Vehicle Part,accessory sector of the Euronext with ticker ALCUR. The last closing price for Arcure was 4.67 €. Over the last year, Arcure shares have traded in a share price range of 3.15 € to 6.96 €.

Arcure currently has 5,745,489 shares in issue. The market capitalisation of Arcure is 26.83 € million. Arcure has a price to earnings ratio (PE ratio) of 14.77.

ALCUR Últimas noticias

Más noticias
No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.21-4.338842975214.844.924.5325244.7217752DE
40.4811.56626506024.154.954.02189974.67976718DE
120.388.941176470594.256.123.96297834.88695756DE
26-2.05-30.68862275456.686.963.85252285.12691763DE
520.8823.46666666673.756.963.15341894.97897556DE
1560.9626.15803814713.676.961.84168974.19299083DE
2600.286.43678160924.356.961.84126414.08408027DE

ALCUR - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Arcure?
El precio actual de las acciones de Arcure es 4.63 €
¿Cuántas acciones de Arcure están en circulación?
Arcure tiene 5,745,489 acciones en circulación
¿Cuál es la capitalización de mercado de Arcure?
La capitalización de mercado de Arcure es EUR 26.83M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Arcure?
Arcure ha negociado en un rango de 3.15 € a 6.96 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Arcure?
El ratio precio/beneficio de Arcure es 14.77
¿Cuál es el ratio de efectivo a ventas de Arcure?
El ratio de efectivo a ventas de Arcure es 1.39
¿Cuál es la moneda de reporte de Arcure?
Arcure presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Arcure?
El último ingresos anual de Arcure es EUR 19.17M
¿Cuál es el último beneficio anual de Arcure?
El último beneficio anual de Arcure es EUR 1.8M
¿Cuál es la dirección registrada de Arcure?
La dirección registrada de Arcure es TOUR ESSOR - 13EME ETAGE -14 RUE SCANDICCI, PANTIN, SEINE-SAINT-DENIS, 93500
¿Cuál es la dirección del sitio web de Arcure?
La dirección del sitio web de Arcure es www.arcure-bourse.com
¿En qué sector industrial opera Arcure?
Arcure opera en el sector MOTOR VEHICLE PART,ACCESSORY

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
DRVDSDrone Volt
0.0039 €
(3,800.00%)
774.48k
GTRDSGroupe Tera DS
0.0585 €
(800.00%)
3.27k
ALCYBCybergun
0.0002 €
(100.00%)
3.98M
DMSBSDiagnostic Medical Systems
0.0075 €
(87.50%)
129.59k
NICBSNicox SA
0.0265 €
(50.57%)
979
MLSMLSmalto
0.014 €
(-33.33%)
1.62k
ALVERVergnet
0.0015 €
(-21.05%)
97.17M
MLIDSIds
0.364 €
(-19.11%)
1.12k
MCPGrupo Media Capital Sgps Sa
1.62 €
(-19.00%)
3
ALBOOBOOSTHEAT
0.063 €
(-15.78%)
70.91k
ATOAtos SE
0.002 €
(-4.76%)
2.53B
ALVERVergnet
0.0015 €
(-21.05%)
97.17M
BCPBanco Comercial Portugues SA
0.4988 €
(0.79%)
69.25M
EDPEDP SA
3.149 €
(1.22%)
13.56M
VIVVivendi SE
2.546 €
(-1.01%)
8.93M

Discusión

Ver feed completo
Dodger1 Dodger1 3 minutos hace
https ://www.juliawalck.com/shop/p/egg-on-your-face-art-print

$AABB
AABB
TightCoil TightCoil 3 minutos hace
We have to be wary of a Release with Conditions -
We must Fight, Fight, Fight For, INSIST ON:

UNCONDITIONAL RELEASE
FNMA
santafe2 santafe2 3 minutos hace
While all the focus is on tech criminals the real problem may be the crypto Ponzi scheme. They spent reportedly $170MM to get him elected. There's a reason he loves the poorly educated. This is the message heard loud and clear by everyone from banking to investment and, of course, every criminal in
quester614 quester614 7 minutos hace
MovyChem was a SCAM company along with Xeriant SRO. MovyChem EU is gone . No website for either. A company that took 20 years to develop Retacell just disappears. I have shown before that Xeriant SRO & MovyChem were started by Vladimír Bíža who can be tracked back to Aegea Inc/ Futureworld SCAM He a
XERI
3331 3331 8 minutos hace
BIEL: HUGE HIT IN TAIWAN!
https://www.actipatchtw.com/general-1
dinogreeves dinogreeves 10 minutos hace
Once they kill all the options by the dead line, this will run. Market makers are begging for mercy they don't report before the deadline, they have probably colluded with the insiders too, it is plausible. The quote below is from someone on Stocktwits. Essentially I am not to only one with commo
SMCI
Werbe Werbe 13 minutos hace
Everyone that posts here start with some extraordinary story of upbringing or some sort of passive social shout.  Anyone a high-school dropout or start from welfare?  
CrypticDomain141 CrypticDomain141 16 minutos hace
I’ve done my research and I’m long.

I don’t understand why everyone is so shocked that this is still volatile at this time. It doesn’t have any revenue yet, and it doesn’t have a big pharm partner….yet.

But from the clinical trials it seems they’ve got the goods. The C
AVXL
Drugdoctor Drugdoctor 19 minutos hace
Here is our CEO's stock chart pattern... Soon we will see $SRNW sporting the same pattern.

https://investorshub.advfn.com/uimage/uploads/2025/1/17/yrkgpGVSI_1-17.png
SRNW
AlwaysOptimistic AlwaysOptimistic 19 minutos hace
I also saw that. Of course Chambers would take that position. He has a lot of capital invested in AI and other tech with his venture funding group (JC2 Ventures) and a lot to lose if investors siphon money away from AI in to quantum. Just like NVDIA. This too shall pass IMO.
IONQ
SSKILLZ1 SSKILLZ1 19 minutos hace
Why Pete would play there now is beyond me. Maybe he has a love of public humiliation?

I have no clue why either. At this point. Which is why I would be shocked if he comes back at this point.

One thing for sure: any Mets solution at first base that includes regularly p
4u2nv2 4u2nv2 19 minutos hace
I have looked at a lot of charts on IFUS. 1M, 1Y, 5Y and I specifically focused on the volume and PPS movement. I did say recently that I am not trading this stock. I do not own any or plan on buying it. I am more focused on a private business model than trading OTC or any stocks. But the IFUS PPS h
IFUS
nowwhat2 nowwhat2 19 minutos hace
Charts are just totally freaking SCREAMING that it COULD be a "Sell The News" Event......and yet ?

It's like.....



https://investorshub.advfn.com/uimage/uploads/2025/1/17/zvqmlxrp_!_17_hyper_845pm_CALVIN_INAUG_PARADE_ATH.jpg



XRPUSD
littlejohn littlejohn 20 minutos hace
SMCI will be at 47 to 48 in a Pop

before we can read the 10K

filing header...

That is why you gotta be ready before

it is filed...

Around $48 is the recent trading high

that market makers marked that may
SMCI
Drugdoctor Drugdoctor 22 minutos hace
Remember, assets from other stock mergers will be added to $FORW's holding company. Right now, something is happening with American Blockchain ($GVSI), our CEO's other shell, and if it is the first to merger, some assets will be coming here. Can't wait for $FORW's chart to look like this.
FORW
MONTANAJOE MONTANAJOE 22 minutos hace
Just amuse each other with their nonsense!
NBRI
TucsonPhil TucsonPhil 22 minutos hace
Wow. According to OTC markets, the OS count is now 5,988,649,454. Last time I checked was last year, and I recall it was around 3.9B, when the AS was 5B, then they raised the AS to 10B and have been busy with quite a bit of dilution.
KGKG
MONTANAJOE MONTANAJOE 22 minutos hace
Like it better when they just talk to each other and leave everyone else alone!!
NBRI
againstallodds againstallodds 24 minutos hace
https://investorshub.advfn.com/uimage/uploads/2025/1/17/rarvyIMG_0265.jpeg

0.5 oz of rhodium per ton of ore can be considered a very high-grade deposit. Here's why:
* Rhodium is extremely rare: It's one of the rarest and most valuable precious metals.
* Typical grades
NBRI
EarningsCentral EarningsCentral 27 minutos hace
TLRY
Drugdoctor Drugdoctor 28 minutos hace
Who made 300% gains-with-George-Sharp's-$GVSI??>>

https://investorshub.advfn.com/uimage/uploads/2025/1/17/yrkgpGVSI_1-17.png
GVSI
axelvento axelvento 28 minutos hace
Moderna is preparing to advance mRNA-1018 into Phase 3. The Company looks forward to sharing the Phase 1/2 results at an upcoming scientific meeting.
MRNA
gitreal gitreal 29 minutos hace
Could it be Mt Vernon assays are flawed, and that the extraordibary Rhodiun assays are skewed ?

Skewed? No.
Made up? Yes.
NBRI
Drugdoctor Drugdoctor 29 minutos hace
Check the accumulation line on chart>>>

https://investorshub.advfn.com/uimage/uploads/2025/1/17/yrkgpGVSI_1-17.png
GVSI
sylvia07 sylvia07 30 minutos hace
Where are the BASHERS when good news is announced, always missing?
GRST

Su Consulta Reciente

EU
ALCUR
Arcure
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados